The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers
NCT03017768 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2017-06-28
Summary
Esophageal hypersensitivity is considered an important pathophysiological mechanism in patients suffering form non-erosive gastro-esophageal reflux disease. Serotonin (5-HT) is predominantly found in the central nervous system and in the gastro-intestinal (GI) tract. 5-HT plays a major role in the regulation of GI secretion, motility and sensitivity, and has been associated with emotion regulation. Acute tryptophan depletion (ATD) temporarily reduces the availability of tryptophan (TRP), thereby decreasing central and peripheral 5-HT synthesis. From previous studies, ATD is known to affect GI physiology and enhance visceral pain perception in the colon. The aim of the study was to investigate the effect of ATD on esophageal sensitivity in healthy volunteers (HV).
Esophageal multimodal sensitivity was assessed after intragastric infusion of an amino-acid mixture (AA-mix) containing 15 AAs with TRP (control condition) or without TRP (ATD condition). After an incubation period of 5 hours, a probe with a polyurethane bag was positioned in the distal esophagus. Thermal (recirculating a heated saline solution through the bag), mechanical (increasing bag volume), electrical (2 stimulation electrodes) and chemical sensitivity (modified Bernstein) were tested and at 3 time points blood samples were collected for biochemical analysis. General mood was assessed by the Positive and Negative Affect Schedule (PANAS) and the State-Trait Anxiety Inventory (STAI) questionnaires.
Conditions
- Esophageal Sensitivity
Interventions
- DIETARY_SUPPLEMENT
-
Acute tryptophan depletion
an amino-acid mixture will be administered without tryptophan (active comparator). After an incubation period of 5 hours esophageal sensitivity will be assessed by multimodal stimulation to evaluate the effect of depleted tryptophan levels on esophageal sensitivity
- DIETARY_SUPPLEMENT
-
Placebo
an amino-acid mixture with tryptophan (placebo mixture) will be administered. After an incubation period of 5 hours esophageal sensitivity will be assessed by multimodal stimulation
- DEVICE
-
Multimodal stimulation probe
The multimodal esophageal probe allows to perform 4 types of stimulations in the esophagus (thermal, mechanical, electrical and chemical stimulation). These 4 modalities will be evaluated to assess esophageal sensitivity.
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Jan Tack, M.D., PhD · TARGID, KU Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2017-03-24
- Completion
- 2017-03-24
Countries
- Belgium
Study Locations
More Related Trials
-
The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers.
NCT03183310 ·Status: UNKNOWN ·Phase: NA
-
Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients
NCT01065649 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers
NCT02736734 ·Status: COMPLETED ·Phase: PHASE4
-
Esophageal capsaïcin Infusion and Mucosal Integrity
NCT02603783 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)
NCT00730665 ·Status: TERMINATED ·Phase: PHASE2
-
The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux
NCT00462137 ·Status: COMPLETED
-
Effects of 6-month of Treatment With TRPV1 and TRPA1 Agonists in Older Patients With OD
NCT05958173 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers
NCT03402984 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn
NCT01753128 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of MIST on Esophageal Sensitivity in Patients With rGERD
NCT05429034 ·Status: UNKNOWN ·Phase: NA
-
SThe Effects of Melatonin on GERD Symptoms
NCT00564590 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula
NCT02425423 ·Status: COMPLETED ·Phase: PHASE3
-
Do Acid Sensing Ion Channels Contribute to Heartburn?
NCT01095133 ·Status: COMPLETED ·Phase: PHASE1
-
14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations
NCT00813306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
NCT00524251 ·Status: COMPLETED
-
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
NCT00830115 ·Status: COMPLETED
-
The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
NCT00915616 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of Itopride vs Placebo in Heartburn
NCT00382577 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
NCT01043185 ·Status: COMPLETED ·Phase: PHASE2
-
Subacute Effect of Pharyngeal Pharmacological Sensory Stimulation in Elderly Patients With Oropharyngeal Dysphagia
NCT04741620 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects
NCT01154634 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients
NCT01797939 ·Status: COMPLETED